Effect of Saroglitazar on Glycemic Status: A Meta-analysis

20250 citationsJournal Articlediamond Open Access

Authors

Sandhiya Selvarajan · Jawaharlal Institute of Post Graduate Medical Education and Research

Anandabaskar Nishanthi · Sri Manakula Vinayagar Medical College and Hospital

Ilanthamizhan Jayakumar · Sri Ramachandra Institute of Higher Education and Research

Shravan Venkatraman · Jawaharlal Institute of Post Graduate Medical Education and Research

Santhosh Shivabasappa · Indra (Spain)

Jayaprakash Sahoo · Jawaharlal Institute of Post Graduate Medical Education and Research

Abstract

Our meta-analysis has found that saroglitazar causes a significant reduction in the HbA<sub>1c</sub>, FBS, and PPBS levels in patients treated for diabetic dyslipidemia.

Topics & Keywords

Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Treatment and Management Blood Pressure and Hypertension Studies

Publication Details

Published in: Cureus

Volume 17, Issue 12, pp. e99122-e99122

DOI: 10.7759/cureus.99122

Field-Weighted Citation Impact: 0.00

Command Palette

Effect of Saroglitazar on Glycemic Status: A Meta-analysis

Authors

Abstract

Topics & Keywords

Publication Details